Elective semaglutide prescription enabled waitlisting and transplantation of otherwise ineligible obese renal transplant candidates
{{output}}
Although transplantation remains the treatment of choice for end-stage renal disease, patients suffering from severe obesity are too often unlisted for this reason. Pre-transplant bariatric surgery is not free of risk and the use of 'Glucagon Like Peptide-1'... ...
